Cargando…
Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs
Topical therapies constitute the mainstay of dermatological treatments for skin disorders, such as atopic dermatitis, contact dermatitis, psoriasis, or acne. Since some of these diseases are often chronic, treatment duration may last for years and may even last the patient's entire lifetime. Ob...
Autores principales: | Lerche, Catharina M., Wulf, Hans Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211469/ https://www.ncbi.nlm.nih.gov/pubmed/25386250 http://dx.doi.org/10.4081/dr.2010.e13 |
Ejemplares similares
-
Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use
por: Gutfreund, Katarzyna, et al.
Publicado: (2013) -
A Treatise on Topical Corticosteroid in Dermatology
por: Sarkar, Somenath
Publicado: (2018) -
Anti‐inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone
por: Mose, Kristian F., et al.
Publicado: (2018) -
Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
por: Siegfried, Elaine C., et al.
Publicado: (2016) -
Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach
por: Das, Anupam, et al.
Publicado: (2017)